Literature DB >> 18832677

Differential pathways govern CD4+ CD28- T cell proinflammatory and effector responses in patients with coronary artery disease.

Behnam Zal1, Juan C Kaski, Julius P Akiyu, Della Cole, Gavin Arno, Jan Poloniecki, Alejandro Madrigal, Anthony Dodi, Christina Baboonian.   

Abstract

Patients with acute coronary syndromes experience circulatory and intraplaque expansion of an aggressive and unusual CD4(+) lymphocyte subpopulation lacking the CD28 receptor. These CD4(+)CD28(-) cells produce IFN-gamma and perforin, and are thought to play an important role in coronary atheromatous plaque destabilization. Aberrant expression of killer Ig-like receptors (KIRs) in CD4(+)CD28(-) cells is broadly thought to be responsible for their cytotoxicity, but the mechanisms involved remain poorly defined. We therefore sought to investigate the mechanism and regulation of CD4(+)CD28(-) cell functionality using T cell clones (n = 536) established from patients with coronary artery disease (n = 12) and healthy volunteers (n = 3). Our functional studies demonstrated that KIR2DS2 specifically interacted with MHC class I-presenting human heat shock protein 60 (hHSP60) inducing cytotoxicity. Further investigations revealed the novel finding that hHSP60 stimulation of TCR alone could not induce a cytotoxic response, and that this response was specific and KIR dependent. Analysis of CD4(+)CD28(-)2DS2(+) clones (n = 162) showed that not all were hHSP60 cytotoxic; albeit, their prevalence correlated with coronary disease status (p = 0.017). A higher proportion of clones responded to hHSP60 by IFN-gamma compared with perforin (p = 0.008). In this study, for the first time, we define the differential regulatory pathways involved in CD4(+)CD28(-) cell proinflammatory and effector responses. We describe in this study that, contrary to previous reports, CD4(+)CD28(-) cell recognition and killing can be specific and discriminate. These results, in addition to contributing to the understanding of CD4(+)CD28(-) cell functionality, may have implications for the monitoring and management of coronary artery disease progression.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18832677     DOI: 10.4049/jimmunol.181.8.5233

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  14 in total

Review 1.  T Cells Going Innate.

Authors:  Midas Seyda; Abdallah Elkhal; Markus Quante; Christine S Falk; Stefan G Tullius
Journal:  Trends Immunol       Date:  2016-07-08       Impact factor: 16.687

Review 2.  Role of unusual CD4+ CD28- T cells in acute coronary syndrome.

Authors:  Wenjie Sun; Lihui Zheng; Lijuan Huang
Journal:  Mol Biol Rep       Date:  2011-06-22       Impact factor: 2.316

Review 3.  CD28 negative T cells: is their loss our gain?

Authors:  D Mou; J Espinosa; D J Lo; A D Kirk
Journal:  Am J Transplant       Date:  2014-10-16       Impact factor: 8.086

4.  Killer cell immunoglobulin receptor profile on CD4(+)  CD28(-) T cells and their pathogenic role in non-dialysis-dependent and dialysis-dependent chronic kidney disease patients.

Authors:  Behnam Zal; Nihil Chitalia; Yin Sing Ng; Verna Trieu; Sana Javed; Rachelle Warrington; Juan Carlos Kaski; Debasish Banerjee; Christina Baboonian
Journal:  Immunology       Date:  2015-05       Impact factor: 7.397

5.  Leukocyte recruitment and ischemic brain injury.

Authors:  Gokhan Yilmaz; D Neil Granger
Journal:  Neuromolecular Med       Date:  2009-07-05       Impact factor: 3.843

Review 6.  Cytotoxic lymphocytes and atherosclerosis: significance, mechanisms and therapeutic challenges.

Authors:  Tin Kyaw; Karlheinz Peter; Yi Li; Peter Tipping; Ban-Hock Toh; Alex Bobik
Journal:  Br J Pharmacol       Date:  2017-06-13       Impact factor: 8.739

7.  Peripheral frequency of CD4+ CD28- cells in acute ischemic stroke: relationship with stroke subtype and severity markers.

Authors:  Antonino Tuttolomondo; Rosaria Pecoraro; Alessandra Casuccio; Domenico Di Raimondo; Carmelo Buttà; Giuseppe Clemente; Vittoriano Della Corte; Giuliana Guggino; Valentina Arnao; Carlo Maida; Irene Simonetta; Rosario Maugeri; Rosario Squatrito; Antonio Pinto
Journal:  Medicine (Baltimore)       Date:  2015-05       Impact factor: 1.889

8.  CTLA4-Ig prolongs graft survival specifically in young but not old mice.

Authors:  Timm Heinbokel; Markus Quante; Jasper Iske; Yeqi Nian; Ryoichi Maenosono; Koichiro Minami; Yang Liu; Haruhito Azuma; Abdallah Elkhal; Stefan G Tullius
Journal:  Am J Transplant       Date:  2020-09-03       Impact factor: 8.086

9.  When Aging Reaches CD4+ T-Cells: Phenotypic and Functional Changes.

Authors:  Marco Antonio Moro-García; Rebeca Alonso-Arias; Carlos López-Larrea
Journal:  Front Immunol       Date:  2013-05-10       Impact factor: 7.561

10.  Molecular mechanisms involved in the aging of the T-cell immune response.

Authors:  Marco Antonio Moro-García; Rebeca Alonso-Arias; Carlos López-Larrea
Journal:  Curr Genomics       Date:  2012-12       Impact factor: 2.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.